| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Michele Carbone | |
| Fang Qi | |||
| Giovanni Gaudino | |||
| Haining Yang | |||
| P2860 | cites work | Seroepidemiology of human polyomaviruses | Q21089620 |
| A very late viral protein triggers the lytic release of SV40 | Q21559509 | ||
| SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis | Q24658316 | ||
| Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters | Q24676844 | ||
| Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters | Q27488312 | ||
| The vacuolating virus, S.V. 40 | Q28187424 | ||
| TNF-alpha inhibits asbestos-induced cytotoxicity via a NF-kappaB-dependent pathway, a possible mechanism for asbestos-induced oncogenesis | Q28389414 | ||
| Malignant mesothelioma: facts, myths, and hypotheses | Q28390539 | ||
| Cellular and molecular parameters of mesothelioma | Q28391676 | ||
| A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. | Q30984959 | ||
| Lymphoproliferative disorders in Costa Rica and simian virus 40. | Q45421899 | ||
| Absence of simian virus 40 DNA sequences in primary central nervous system lymphoma in HIV-negative patients | Q45660414 | ||
| Clinical and Serologic Responses in Volunteers Given Vacuolating Virus (SV40) by Respiratory Route | Q45711479 | ||
| EXCRETION OF SV-40 VIRUS AFTER ORAL ADMINISTRATION OF CONTAMINATED POLIO VACCINE | Q45713596 | ||
| Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas | Q45731423 | ||
| Simian virus 40 DNA sequences in human brain and bone tumours. | Q45753428 | ||
| Simian virus 40-like DNA sequences in human pleural mesothelioma. | Q45778487 | ||
| Transformation of astrocytes and destruction of spongioblasts induced by a simian tumor virus (SV40) in cultures of human fetal neuroglia | Q45826069 | ||
| Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model | Q45856252 | ||
| Glucagon gene 5'-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice | Q45866297 | ||
| Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice | Q45872028 | ||
| DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood | Q45880317 | ||
| Transgenic model of cardiac rhabdomyosarcoma formation | Q46233037 | ||
| Tumor agonist peptides break tolerance and elicit effective CTL responses in an inducible mouse model of hepatocellular carcinoma. | Q46695945 | ||
| Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences. | Q46698594 | ||
| SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice | Q48467800 | ||
| Association of SV40 with human tumors | Q48684971 | ||
| SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study. | Q53358874 | ||
| Morphological and virological investigation of human tissue cultures transformed with SV40. | Q53437994 | ||
| Transformation mediated by the SV40 T antigens: separation of the overlapping SV40 early genes with a retroviral vector. | Q53551047 | ||
| SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure. | Q53854583 | ||
| Detection of SV40 in colon cancer: a molecular case-control study from northeast Italy. | Q54425954 | ||
| SV40 detection in human tumor specimens. | Q54632765 | ||
| GM1 structure determines SV40-induced membrane invagination and infection | Q58830543 | ||
| SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals | Q71095269 | ||
| SV40-like sequences in human bone tumors | Q71405312 | ||
| Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis | Q73281417 | ||
| Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma | Q73332481 | ||
| Generation of tumors in transgenic mice expressing the SV40 T antigen under the control of ovarian-specific promoter 1 | Q73419106 | ||
| Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice | Q73692219 | ||
| Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome | Q74332896 | ||
| Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines | Q77950098 | ||
| Public health. Creeping consensus on SV40 and polio vaccine | Q78425657 | ||
| The TRAMP mouse as a model for prostate cancer | Q81141767 | ||
| SV40 infection in human cancers | Q81684899 | ||
| SV40 and p53 as team players in childhood lymphoproliferative disorders | Q83602276 | ||
| A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen | Q44598425 | ||
| Evaluation of SV40 in osteosarcoma and healthy population: a Hungarian-German study. | Q44624635 | ||
| Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey | Q44815866 | ||
| No implication of Simian virus 40 in pathogenesis of malignant pleural mesothelioma in Slovenia | Q45369276 | ||
| Detection of simian virus 40 DNA sequences in Egyptian patients with different hematological malignancies | Q45400653 | ||
| Asbestos in Italy | Q33205291 | ||
| Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories | Q33208129 | ||
| Cellular transcription factor Sp1 recruits simian virus 40 capsid proteins to the viral packaging signal, ses. | Q33292406 | ||
| Frequent detection of polyomaviruses in stool samples from hospitalized children | Q33567205 | ||
| A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells | Q33585069 | ||
| Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells | Q33870418 | ||
| SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma | Q33946963 | ||
| Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. | Q34004850 | ||
| Role of SV40 integration site at chromosomal interval 1q21.1 in immortalized CRL2504 cells | Q34035772 | ||
| SV40 and human tumours: myth, association or causality? | Q34161997 | ||
| SV40 in human brain cancers and non-Hodgkin's lymphoma | Q34221199 | ||
| SV40 associated miRNAs are not detectable in mesotheliomas | Q34253734 | ||
| Simian virus 40 infection in humans and association with human diseases: results and hypotheses | Q34305045 | ||
| SV40 induces mesotheliomas in hamsters | Q34355997 | ||
| Prostate cancer in a transgenic mouse | Q34444393 | ||
| Negative regulation of mitotic promoting factor by the checkpoint kinase chk1 in simian virus 40 lytic infection | Q34464422 | ||
| Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. | Q34467643 | ||
| The VP2/VP3 minor capsid protein of simian virus 40 promotes the in vitro assembly of the major capsid protein VP1 into particles | Q34494580 | ||
| The role of SV40 in malignant mesothelioma and other human malignancies | Q34558970 | ||
| Is there a role for SV40 in human cancer? | Q34565021 | ||
| Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome | Q34608139 | ||
| Influence of the viral regulatory region on tumor induction by simian virus 40 in hamsters | Q34708628 | ||
| Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation | Q34714730 | ||
| Tissue Tropism of SV40 Transformation of Human Cells: Role of the Viral Regulatory Region and of Cellular Oncogenes. | Q34972602 | ||
| Simian virus 40-related antigens in three human meningiomas with defined chromosome loss | Q35070051 | ||
| Molecular dissection of nuclear entry-competent SV40 during infection | Q35740773 | ||
| Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model | Q35829505 | ||
| Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences | Q35894850 | ||
| Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids | Q35903117 | ||
| Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene | Q35903178 | ||
| RAPID TRANSFORMATION OF HUMAN FIBROBLAST CULTURES BY SIMIAN VIRUS | Q36399071 | ||
| Nuclear factor of activated T-cells (NFAT) plays a role in SV40 infection | Q36532824 | ||
| High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients | Q36641726 | ||
| Class I major histocompatibility proteins as cell surface receptors for simian virus 40. | Q36831325 | ||
| Simian virus 40 agnoprotein facilitates perinuclear-nuclear localization of VP1, the major capsid protein. | Q36870740 | ||
| SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma. | Q36944358 | ||
| Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors | Q36956860 | ||
| Detection of polyomavirus SV40 in tonsils from immunocompetent children | Q36977616 | ||
| Polyomavirus shedding in the stool of healthy adults | Q37302101 | ||
| Cell-type specific regulation of gene expression by simian virus 40 T antigens | Q37332894 | ||
| Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. | Q37432550 | ||
| T antigen transgenic mouse models | Q37511197 | ||
| Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent | Q38299833 | ||
| SV40 early-to-late switch involves titration of cellular transcriptional repressors | Q38314769 | ||
| SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor | Q38356646 | ||
| Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations | Q38466301 | ||
| Examination of poliovirus vaccine preparations for SV40 sequences | Q38467661 | ||
| The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas | Q38474132 | ||
| Presence of simian virus 40 DNA sequences in diffuse large B-cell lymphomas in Tunisia correlates with aberrant promoter hypermethylation of multiple tumor suppressor genes. | Q38872031 | ||
| Evidence for a role of the Simian Virus 40 in human breast carcinomas. | Q39039525 | ||
| Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma | Q39624029 | ||
| Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution | Q39865614 | ||
| A novel mechanism of late gene silencing drives SV40 transformation of human mesothelial cells | Q39916361 | ||
| SV 40 related Papova-viruses in human meningiomas | Q39982452 | ||
| Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma. | Q40073685 | ||
| Recovery of strains of the polyomavirus SV40 from rhesus monkey kidney cells dating from the 1950s to the early 1960s | Q40075219 | ||
| SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells | Q40144585 | ||
| A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent | Q40208072 | ||
| Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan | Q40289340 | ||
| Immunodetection of SV40 large T antigen in human central nervous system tumours | Q40442609 | ||
| Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan | Q40504447 | ||
| Reappraisal of the strong association between simian virus 40 and human malignant mesothelioma of the pleura (Belgium). | Q40648112 | ||
| Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells | Q40677575 | ||
| Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas | Q40690026 | ||
| SV40 infection induces telomerase activity in human mesothelial cells. | Q40749324 | ||
| The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor | Q40755750 | ||
| A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas | Q40838265 | ||
| Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice. | Q41231782 | ||
| Simian Virus 40 depends on ER protein folding and quality control factors for entry into host cells | Q41623826 | ||
| Cytogenetic analysis of hepatic cell lines derived from SV40-T antigen gene-harboring transgenic mice | Q41668206 | ||
| A mouse model of ghrelinoma exhibited activated growth hormone-insulin-like growth factor I axis and glucose intolerance | Q42456930 | ||
| Sequence analyses of human tumor-associated SV40 DNAs and SV40 viral isolates from monkeys and humans | Q42677570 | ||
| An E2F binding sequence negatively regulates the response of the insulin-like growth factor 1 (IGF-I) promoter to simian virus 40T antigen and to serum. | Q42834977 | ||
| The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols | Q43010950 | ||
| Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes | Q43470250 | ||
| Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma | Q43558001 | ||
| Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. | Q43624473 | ||
| The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth | Q43768378 | ||
| Molecular identification of SV40 infection in human subjects and possible association with kidney disease | Q44193216 | ||
| Cell and molecular biology of simian virus 40: implications for human infections and disease | Q44314704 | ||
| P433 | issue | 5 | |
| P921 | main subject | brain tumor | Q233309 |
| SV40 | Q734305 | ||
| P304 | page(s) | 683-697 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | Expert Review of Respiratory Medicine | Q15754583 |
| P1476 | title | Simian virus 40 transformation, malignant mesothelioma and brain tumors | |
| P478 | volume | 5 |
| Q91826188 | A fail-safe system to prevent oncogenesis by senescence is targeted by SV40 small T antigen |
| Q37458983 | Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis |
| Q92557659 | Association Between Simian Virus 40 and Human Tumors |
| Q36295924 | CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma |
| Q34339983 | Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy? |
| Q42250611 | Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants. |
| Q92134506 | Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation |
| Q51795590 | HGF/Met Signaling Is a Key Player in Malignant Mesothelioma Carcinogenesis. |
| Q36102815 | Human BK Polyomavirus-The Potential for Head and Neck Malignancy and Disease |
| Q27025941 | Matrix and backstage: cellular substrates for viral vaccines |
| Q36480216 | NLRP1 polymorphisms in patients with asbestos-associated mesothelioma |
| Q26825296 | Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator |
| Q42246313 | No evidence of Polyomavirus and EBV infections in Italian patients with mixed cryoglobulinemia infected chronically with HCV. |
| Q38401479 | Parakeratotic-like cells in effusions - A clue to diagnosis of malignant mesothelioma |
| Q90612176 | SV40 and human mesothelioma |
| Q38081973 | SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier |
| Q37743114 | Serum IgG Antibodies from Pregnant Women Reacting to Mimotopes of Simian Virus 40 Large T Antigen, the Viral Oncoprotein. |
| Q39575359 | Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis |
| Q34520540 | Survey for human polyomaviruses in cancer |
| Q29248727 | Switching off malignant mesothelioma: exploiting the hypoxic microenvironment |
| Q38148036 | The function, mechanisms, and role of the genes PTEN and TP53 and the effects of asbestos in the development of malignant mesothelioma: a review focused on the genes' molecular mechanisms |
Search more.